Suppr超能文献

线粒体疾病成年患者的死因

Causes of Death in Adults with Mitochondrial Disease.

作者信息

Barends Marlieke, Verschuren Lotte, Morava Eva, Nesbitt Victoria, Turnbull Doug, McFarland Robert

机构信息

Nijmegen Centre for Mitochondrial Disorders and Department of Pediatrics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

Wellcome Trust Centre for Mitochondrial Research, Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UK.

出版信息

JIMD Rep. 2016;26:103-13. doi: 10.1007/8904_2015_449. Epub 2015 Sep 10.

Abstract

INTRODUCTION

Mitochondrial diseases are a clinically, biochemically and genetically heterogeneous group of disorders with a variable age of onset and rate of disease progression. It might therefore be expected that this variation be reflected in the age and cause of death. However, to date, little has been reported regarding the 'end-of-life' period and causes of death in mitochondrial disease patients. For some specific syndromes, the associated clinical problems might predict the cause of death, but for many patients, it remains difficult to provide an accurate prognosis.

AIMS

To describe a retrospective cohort of adult mitochondrial disease patients who had attended the NHS Highly Specialised Services for Rare Mitochondrial Diseases in Newcastle upon Tyne (UK), evaluate life expectancy and causes of death and assess the consequences for daily patient care.

METHODS

All deceased adult patients cared for at this centre over a period of 10 years were included in the study. Patient history, data on laboratory findings, biochemical investigations and genetic studies were analysed retrospectively.

RESULTS

A total of 30 adult mitochondrial patients died within the time period of the study. The main mitochondrial disease-related causes of death in this patient cohort were respiratory failure, cardiac failure and acute cerebral incidents such as seizures and strokes. In almost half of the patients, the cause of death remained unknown. Based on our study, we present recommendations regarding the care of patients with mitochondrial disease.

摘要

引言

线粒体疾病是一组在临床、生化和遗传方面具有异质性的疾病,发病年龄和疾病进展速度各不相同。因此,可以预期这种差异会反映在死亡年龄和死因上。然而,迄今为止,关于线粒体疾病患者的“临终”期和死因的报道很少。对于一些特定综合征,相关的临床问题可能预示着死因,但对于许多患者来说,仍然难以提供准确的预后。

目的

描述一组曾在英国泰恩河畔纽卡斯尔的国民保健服务(NHS)高度专业化罕见线粒体疾病服务中心就诊的成年线粒体疾病患者的回顾性队列,评估预期寿命和死因,并评估对患者日常护理的影响。

方法

本研究纳入了该中心在10年期间护理的所有已故成年患者。对患者病史、实验室检查结果、生化检查和基因研究数据进行回顾性分析。

结果

在研究期间,共有30名成年线粒体疾病患者死亡。该患者队列中与线粒体疾病相关的主要死因是呼吸衰竭、心力衰竭以及癫痫发作和中风等急性脑部事件。几乎一半患者的死因不明。基于我们的研究,我们提出了关于线粒体疾病患者护理的建议。

相似文献

1
Causes of Death in Adults with Mitochondrial Disease.
JIMD Rep. 2016;26:103-13. doi: 10.1007/8904_2015_449. Epub 2015 Sep 10.
3
Pediatric stroke among Hong Kong Chinese subjects.
Pediatrics. 2004 Aug;114(2):e206-12. doi: 10.1542/peds.114.2.e206.
7
Life expectancy and causes of death in patients with Myotonic Dystrophy Type 2.
J Neuromuscul Dis. 2024 Nov;11(6):1221-1228. doi: 10.3233/JND-240089.
9
Causes of death in a contemporary adult congenital heart disease cohort.
Heart. 2018 Oct;104(20):1678-1682. doi: 10.1136/heartjnl-2017-312777. Epub 2018 Apr 17.
10
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.
Lancet. 1997 May 24;349(9064):1498-504. doi: 10.1016/S0140-6736(96)07492-2.

引用本文的文献

2
Energy Metabolism and Brain Aging: Strategies to Delay Neuronal Degeneration.
Cell Mol Neurobiol. 2025 Apr 21;45(1):38. doi: 10.1007/s10571-025-01555-z.
3
5
A platform to map the mind-mitochondria connection and the hallmarks of psychobiology: the MiSBIE study.
Trends Endocrinol Metab. 2024 Oct;35(10):884-901. doi: 10.1016/j.tem.2024.08.006. Epub 2024 Oct 9.
6
Mitochondrial myopathies diagnosed in adulthood: clinico-genetic spectrum and long-term outcomes.
Brain Commun. 2024 Feb 14;6(2):fcae041. doi: 10.1093/braincomms/fcae041. eCollection 2024.
7
Hypermetabolism and energetic constraints in mitochondrial disorders.
Nat Metab. 2024 Feb;6(2):192-195. doi: 10.1038/s42255-023-00968-8.
8
Characterization of Fatigue in Primary Mitochondrial Myopathies: Findings From a Qualitative Interview Study.
Neurol Clin Pract. 2024 Feb;14(1):e200229. doi: 10.1212/CPJ.0000000000200229. Epub 2023 Dec 22.
9
Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.
BMC Med. 2023 May 24;21(1):189. doi: 10.1186/s12916-023-02893-9.

本文引用的文献

1
Cardiac manifestations of primary mitochondrial disorders.
Int J Cardiol. 2014 Dec 20;177(3):754-63. doi: 10.1016/j.ijcard.2014.11.014. Epub 2014 Nov 5.
2
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation.
Neurology. 2013 May 28;80(22):2049-54. doi: 10.1212/WNL.0b013e318294b44c. Epub 2013 May 1.
3
Hereditary myopathy with early respiratory failure: occurrence in various populations.
J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):345-53. doi: 10.1136/jnnp-2013-304965. Epub 2013 Apr 19.
4
Pulmonary issues in patients with chronic neuromuscular disease.
Am J Respir Crit Care Med. 2013 May 15;187(10):1046-55. doi: 10.1164/rccm.201210-1804CI.
5
Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers.
Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):650-8. doi: 10.1093/ehjci/jes226. Epub 2012 Nov 4.
6
Psychiatric involvement in adult patients with mitochondrial disease.
Neurol Sci. 2013 Jan;34(1):71-4. doi: 10.1007/s10072-011-0901-0. Epub 2011 Dec 23.
8
Nature and frequency of respiratory involvement in chronic progressive external ophthalmoplegia.
J Neurol. 2011 Nov;258(11):2020-5. doi: 10.1007/s00415-011-6060-7. Epub 2011 May 1.
10
Gastrointestinal dysfunction in Parkinson's disease.
Parkinsonism Relat Disord. 2011 Jan;17(1):10-5. doi: 10.1016/j.parkreldis.2010.08.003. Epub 2010 Sep 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验